Device-free
no extra hardware required
AI-Powered Respiratory Decision Support
Every Breath Matters.
AI-powered respiratory decision support for young children — using only a smartphone camera.
Live respiratory signal
The problem
Respiratory assessment in young children is still too subjective.
Children under five are among the most difficult patients to assess objectively during respiratory illness. Traditional lung function tools are often impractical in this age group, and decisions are frequently made under uncertainty — at home, in primary care, and in resource-limited settings. The result is a persistent detection gap: delayed recognition of deterioration, unnecessary emergency visits, and missed opportunities for earlier intervention.
Our solution
A 30-second video. Actionable respiratory insight.
BREASY uses smartphone video analysis to assess breathing motion patterns from the chest and abdomen and generate objective respiratory decision-support outputs. Proof-of-concept evidence for this approach is provided by our peer-reviewed work in Cureus (2025).
Non-contact
no sensors attached to the child
Fast
brief capture during routine care or home monitoring
Accessible
designed for real-world use, including low-resource settings
Clinically grounded
built around respiratory motion and effort-related features
How it works
Three steps to objective respiratory insight.
Our technology turns a short smartphone video into objective respiratory indicators — helping bridge the critical gap between early symptom onset and severe deterioration.
01
Record
Capture a short smartphone video of the child's chest and abdominal breathing.
02
Analyze
BREASY analyzes respiratory motion patterns and derives objective indicators of respiratory status.
03
Support Decision-Making
The platform presents clinically interpretable outputs that help identify children who may require escalation, closer monitoring, or urgent evaluation.
Use cases
Built for the moments when objective respiratory assessment matters most.
BREASY is being developed to support respiratory decision-making across multiple care environments — from the home to the clinic to low-resource frontline care.
Global health focus
AI-enabled respiratory triage in low-resource settings.
BREASY is being developed with a clear global-health mandate — to bring objective respiratory assessment to frontline providers and caregivers in LMIC settings, where access to specialist care and diagnostic tools is limited. Local partnerships are in place in the DRC (Democratic Republic of Congo), supporting planned implementation alongside community health workers and frontline clinicians.
Home monitoring
Supports families and clinicians when respiratory symptoms begin or worsen, helping reduce guesswork and improve communication.
Pediatric asthma & wheeze
Particularly relevant for preschool children, where objective monitoring options are limited and early recognition of deterioration is critical.
Frontline & primary care
Supports more standardized respiratory assessment during routine clinical evaluation.
Global health & pneumonia triage
Designed with future application in low-resource settings (LMIC), where early identification of respiratory distress may improve triage and referral decisions.
Clinical & scientific foundation
Built on clinical insight. Designed for real-world validation.
BREASY is being developed on the basis of clinical respiratory research, computer-vision methods, and prospective pediatric datasets — including a peer-reviewed proof of concept in Cureus (2025), multicenter pediatric data from Israel and Canada, and ongoing collaborations across DRC and global LMIC settings.
- Peer-reviewed
- Cureus
- Target age group
- 0–5
- Required hardware
- 0 devices
Team
Clinical, AI, and product leadership working together.
AS
Adi Sharvas
CEO
Expert in management including cyber and biometrics. Medical startup advisor.
PI
Prof. Israel Amirav
CMO
Pediatric pulmonologist and clinician-researcher for almost 40 years.
YA
Yossi Avni
CTO
AI, cybersecurity, and entrepreneurship expert. 26-time patent holder.
Achievements
From lab to bedside — what we've proven so far.
- Peer-reviewed proof of concept published in Cureus (2025)
- POC in lab settings
- MVP user app for clinical trial usage
- PCT filed
Funding & Partnerships
Backed by institutions that know medtech.
- MoI
- Biodesign
- Schneider
- Road2
Intended use & safety
Designed as decision support — not autonomous diagnosis.
BREASY is intended to support respiratory assessment and triage-related decision-making. It is not intended to replace clinician judgment, emergency evaluation, or standard-of-care assessment. Any final clinical decision, referral, or treatment action remains the responsibility of the healthcare professional.
For parents and caregivers: if a child appears severely unwell or in respiratory distress, seek urgent medical care immediately.
Regulatory status: BREASY is currently under development. It is not cleared, approved, or authorized as a medical device by the FDA, Health Canada, EU CE mark, the Israeli Ministry of Health, or any other regulatory authority. Availability and indications for use may vary by jurisdiction.
Contact
Let's bring objective respiratory assessment to the moments that matter.
Whether you are a clinician, health system partner, researcher, or strategic collaborator, we would welcome the opportunity to connect.